Sort
21,453 grants matching “tuberculosis”
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$746,060Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2019 · AI
Rapid phenotypic detection of complex and emergent TB drug-resistance using a next-generation nanoluciferase reporter phage
$746,037Max O'Donnell · Columbia University Health Sciences · R01 · FY2024 · AI
Handheld and population-based sequencing for rapid detection of new and repurposed drug resistance in M. tuberculosis
$745,941John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2023 · AI
Development of novel penems for drug-resistant tuberculosis
$745,773Craig A Townsend · Johns Hopkins University · R01 · FY2022 · AI
HT Image Assay of Lipid Droplet Formation in Human Adipocytes
$745,749Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2009 · DK
Novel Methods to Inform HIV/TB Clinical Trial Development
$745,684Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2019 · AI
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
$745,616Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2020 · AI
Development of 1,2,4-Triazolyl Compounds and their derivatives as a New Treatment for Tuberculosis
$745,546Christina Leigh Stallings · Washington University · R01 · FY2025 · AI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis
$745,441Courtney C Aldrich · University Of Minnesota · R01 · FY2022 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$745,409Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2017 · AI
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY
$745,284Colorado State University-Fort Collins · P01 · FY2002 · AI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
$745,261Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2018 · OD
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting
$745,231James C M Brust · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Mucosal subunit vaccines against SARS CoV-2
$745,036Purnima Dubey · Ohio State University · R01 · FY2025 · AI
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$745,015Myron E Essex · Harvard School Of Public Health · R01 · FY2009 · AI
Implementation/Evaluation of TB, HIV, and Syphilis Screening in Ethiopian Prisons
$744,999Wondwossen Amogne Degu · Ethiopian Public Health Association · U01 · FY2015 · GH
The Consequences of Reinfection with M. tuberculosis
$744,863Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Chemical probes of vulnerable pathways in antibiotic-resistant pathogens
$744,764Tanya Parish · Access To Advanced Health Institute · R01 · FY2015 · AI
Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients
$744,727Sebastian Seiguer · Emocha Mobile Health, Inc. · R44 · FY2020 · DK
Mechanisms of vitamin A-dependent risk for tuberculosis progression and prevention
$744,535Brendan Podell · Colorado State University · R01 · FY2024 · AI
Autophagy Against Tuberculosis and HIV
$744,529Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI
Autophagy Against Tuberculosis and HIV
$744,529Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2020 · AI
Autophagy Against Tuberculosis and HIV
$744,529Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2019 · AI
Motivational enhancement to augment contingency management for SARS-CoV-2 testing and vaccination utilization among syringe exchange clients
$744,388Anne Marie Mauricio · University Of Oregon · U01 · FY2023 · DA
Translational studies of hookworm infection in Ghana
$744,203Michael Cappello · Yale University · R01 · FY2023 · AI